GREATER CERTAINTY IN DRUG DEVELOPMENT
Certainty by Certara offers exclusive access to industry leaders and clinical researchers with opportunities to achieve better certainty in drug development through the presentations related to Model-informed Drug Development, clinical pharmacology, QSP, PBPK, and more.
You can learn case studies and the latest scientific trends from our special guest speakers and Certara’s experts and ask questions directly. We hope this annual event will help you connect with innovative researchers from various pharmaceutical companies and bring the innovations to your team.
- Location: Shanghai
- Venue: Crowne Plaza Shanghai Jinxiu
- Time: 9am – 5pm
- Registration fee: Free of charge
Featured topics by Certara
Download agenda and details of CERTAINTY China
- Biosimulation at scale: Industrializing quantitative systems pharmacology to guide drug-development decision making
by John M. Burke, PhD, VP, Global Head of ABM Scientific Affairs - Moving from Hype to Reality in Pharmaceutical AI Applications
by Sean McGee, Director of Product, AI - Application of indirect treatment comparison in drug development
by Shuai Fu, Associate Principal Scientist - Forms, Data, Docs: How Certara Cloud Optimizes Trials Towards Submission Readiness
by Philip Johnston, Vice President, Product, Certara - The Era of Generative AI: Revolutionizing the Regulatory writing
by Jean Zhu, Solution Consultant, Certara
Guest Speakers
Download details of speakers’ bio and session information
- Yue Wu, PhD, DMPK Director, Beigene
- Huafang Jiang, Senior Director of Analysis and Bioanalysis, Joinn
- Yi Lin, PhD, Head of AI Data and Digital, Roche
- Hongyun Wang, PhD, Professor, Vice Director, Peking Union Medical College Hospital
- Liu Li, PhD, Professor, China Pharmaceutical University
- Hao Jiang, PhD, Assistant Director, Hengrui
- Victor Wu, PhD, CEO, Data Science Express
